Treatment for acute/chronic ischemic neuronal injury using vanadate
钒酸盐治疗急/慢性缺血性神经元损伤
基本信息
- 批准号:15591534
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Orthovanadate is a competitive inhibitor of protein tyrosine phosphatases. Some of its reported biologic effects are its insulin mimetic property and its activation of phosphoinositide 3-kinase and extracellular-signal regulated kinase(ERK). The authors previously reported its neuroprotective effect on delayed neuronal death of gerbil hippocampal CA1 neurons via Akt and ERK activation after transient forebrain ischemia. In the present study, the neuroprotective effect of postischemic intraperitoneal administration of sodium orthovanadate(2 l/kg of 50-mmol/l sodium orthovanadate in saline) was investigated in rats with transient middle cerebral artery occlusion. Ischemic neuronal injury was evaluated 1 day and 28 days after ischemia. The neuroprotective effect of orthovanadate was significant in the cortex but not the caudate putamen(ischemic core) at both 1 and 28 days after ischemia. In orthovanadate group, the activities of Akt and ERK were maintained after reperfusion ; they were decreased in saline group. Blood glucose level decreased but within normal range.Regional cerebral blood flow was lower than that of saline group only at 0 hours after reperfusion. These data suggest that orthovanadate has neuroprotective effects in rats with transient middle cerebral artery occlusion and that these effects are mediated by Akt and ERK activation. Furthermore, low blood glucose levels and gradual recovery of regional cerebral blood flow may contribute to neuroprotection.Next, we injected vanadte after ischemia. The number of Budr/double cortin positive cells decreased remarkably in SVZ. Thus we concluded that vanadate induced progenitor cells after ischemia.Vanadate may have a potential that induced neuronal regeneration. Further investigation and trial for treatment were needed.
正钒酸盐是蛋白酪氨酸磷酸酶的竞争性抑制剂。一些报道的生物学效应是其胰岛素模拟特性和其磷酸肌醇3-激酶和细胞外信号调节激酶(ERK)的激活。作者先前报道了其通过Akt和ERK激活对短暂前脑缺血后沙土鼠海马CA 1区神经元迟发性神经元死亡的神经保护作用。在本研究中,缺血后腹腔注射原钒酸钠(2 L/kg的50 mmol/L原钒酸钠的生理盐水)的神经保护作用进行了研究,在大鼠短暂的大脑中动脉闭塞。缺血后1天和28天评价缺血性神经元损伤。在缺血后1天和28天,原钒酸盐的神经保护作用在皮质中是显著的,但在尾壳核(缺血核心)中不是。原钒酸钠组再灌注后Akt和ERK活性维持不变,生理盐水组Akt和ERK活性降低。血糖水平下降,但在正常范围内,局部脑血流量仅在再灌注0小时低于生理盐水组。这些数据表明,原钒酸盐具有短暂性大脑中动脉闭塞大鼠的神经保护作用,这些作用是由Akt和ERK激活介导的。此外,低血糖水平和局部脑血流量的逐渐恢复可能有助于神经保护。SVZ中Budr/双皮质素阳性细胞数明显减少。因此,我们认为钒酸盐可以诱导缺血后的神经祖细胞,钒酸盐可能具有诱导神经元再生的潜力。需要进一步的研究和治疗试验。
项目成果
期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tajiri S, Oyadomari S, Yano S, Morioka M et al.: "Ischemia-induced neuronal cell death is mediated by the endoplasmic reticulum stress pathway involving CHOP"Cell Death Differ.. 11(4). 403-415 (2004)
Tajiri S、Oyadomari S、Yano S、Morioka M 等人:“缺血诱导的神经元细胞死亡是由涉及 CHOP 的内质网应激途径介导的”细胞死亡差异.. 11(4)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Multimodal treatment of ruptured dissecting aneurysms of the vertebral artery during the acute stage
- DOI:10.3171/jns.2003.99.6.0960
- 发表时间:2003-12-01
- 期刊:
- 影响因子:4.1
- 作者:Hamada, J;Kai, Y;Ushio, Y
- 通讯作者:Ushio, Y
Ischemia-induced neuronal cell death is mediated by the endoplasmic reticulum stress pathway involving CHOP
- DOI:10.1038/sj.cdd.4401365
- 发表时间:2004-04-01
- 期刊:
- 影响因子:12.4
- 作者:Tajiri, S;Oyadomari, S;Mori, M
- 通讯作者:Mori, M
T Hara, J Hamada, S Yano, M Morioka, et al.: "CREB is required for acquisition of ischemic tolerance in gerbil hippocampal CA1 region"J.Neurochem.. 86. 805-814 (2003)
T Hara、J Hamada、S Yano、M Morioka 等人:“沙鼠海马 CA1 区域的缺血耐受性的获得需要 CREB”J.Neurochem.. 86. 805-814 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Morioka, et al.: "The angiographical dilatation and branch extension of the AchA and P-CoM artery are predictors of hemorrhage in adult moyamoya patients"Stroke. 34. 90-95 (2003)
M.Morioka 等人:“AchA 和 P-CoM 动脉的血管造影扩张和分支延伸是成年烟雾病患者出血的预测因子”中风。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MORIOKA Motohiro其他文献
MORIOKA Motohiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MORIOKA Motohiro', 18)}}的其他基金
Paho-physiologocal study for moyamoya disease : proteomix and neuroimaging analysis
烟雾病的泛美卫生生理学研究:蛋白质组合和神经影像分析
- 批准号:
23592096 - 财政年份:2011
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The study of common cell death pathway between Altzheimer disease and ischemic neuronal cell death
阿尔茨海默病与缺血性神经细胞死亡共同细胞死亡途径的研究
- 批准号:
17591519 - 财政年份:2005
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of phosphorylation reaction of tau factor in ischemic neuronal cell death
tau因子磷酸化反应在缺血性神经细胞死亡中的作用
- 批准号:
13671445 - 财政年份:2001
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
EVALUATION OF ANTI-ADHESION MOLECULE THERAPY AFTER MCA OCCLUSION IN THE RAT
大鼠 MCA 闭塞后抗粘连分子治疗的评价
- 批准号:
6219166 - 财政年份:1999
- 资助金额:
$ 1.98万 - 项目类别:
EVALUATION OF ANTI-ADHESION MOLECULE THERAPY AFTER MCA OCCLUSION IN THE RAT
大鼠 MCA 闭塞后抗粘连分子治疗的评价
- 批准号:
6359002 - 财政年份:1999
- 资助金额:
$ 1.98万 - 项目类别:
EVALUATION OF ANTI-ADHESION MOLECULE THERAPY AFTER MCA OCCLUSION IN THE RAT
大鼠 MCA 闭塞后抗粘连分子治疗的评价
- 批准号:
6112256 - 财政年份:1998
- 资助金额:
$ 1.98万 - 项目类别:
EVALUATION OF ANTI-ADHESION MOLECULE THERAPY AFTER MCA OCCLUSION IN THE RAT
大鼠 MCA 闭塞后抗粘连分子治疗的评价
- 批准号:
6273744 - 财政年份:1998
- 资助金额:
$ 1.98万 - 项目类别:
EVALUATION OF ANTI-ADHESION MOLECULE THERAPY AFTER MCA OCCLUSION IN THE RAT
大鼠 MCA 闭塞后抗粘连分子治疗的评价
- 批准号:
6243589 - 财政年份:1997
- 资助金额:
$ 1.98万 - 项目类别:
ANTI-ICAM-1 ANTIBODY TREATMENT AFTER MCA OCCLUSION
MCA 闭塞后抗 ICAM-1 抗体治疗
- 批准号:
2333008 - 财政年份:1995
- 资助金额:
$ 1.98万 - 项目类别:
ANTI-ICAM-1 ANTIBODY TREATMENT AFTER MCA OCCLUSION
MCA 闭塞后抗 ICAM-1 抗体治疗
- 批准号:
2655495 - 财政年份:1995
- 资助金额:
$ 1.98万 - 项目类别:
ANTI-ICAM-1 ANTIBODY TREATMENT AFTER MCA OCCLUSION
MCA 闭塞后抗 ICAM-1 抗体治疗
- 批准号:
2272530 - 财政年份:1995
- 资助金额:
$ 1.98万 - 项目类别:
ANTI ICAM 1 ANTOBODY TREATMENT AFTER MCA OCCLUSION
MCA 闭塞后抗 ICAM 1 抗体治疗
- 批准号:
2272529 - 财政年份:1995
- 资助金额:
$ 1.98万 - 项目类别:
EVALUATION OF ANTI-ADHESION MOLECULE THERAPY AFTER MCA OCCLUSION IN THE RAT
大鼠 MCA 闭塞后抗粘连分子治疗的评价
- 批准号:
5215218 - 财政年份:
- 资助金额:
$ 1.98万 - 项目类别: